Ars Pharmaceuticals, Inc. · NASDAQ:SPRY
Fitzpatrick Alexander A sold 3,355 Ars Pharmaceuticals, Inc. shares (Form 4)
Traded Jun 12, 2026 · Filed Jun 12, 2026
On Jun 12, 2026, Fitzpatrick Alexander A (Chief Legal Officer) sold 3,355 Ars Pharmaceuticals, Inc. shares at US$10.00 for US$33,550 under a trading plan, leaving 90,910 shares. Filed Jun 12, 2026 (Form 4).
- Sold
- 3,355 shares
- Price
- US$10.00
- Value
- US$33,550
- Holding after
- 90,910 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Legal Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 12, 2026 | Common Stock | Sale | 3,355 | US$10.00 | 90,910 | Direct |
Source
Related
- Ars Pharmaceuticals, Inc.
- Fitzpatrick Alexander A
- Ars Pharmaceuticals, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 14, 2026
- Form 4 · Karas Eric · Jun 12, 2026
- Schedule 13G/A · Rubric Capital Management LP · May 15, 2026
- Schedule 13G/A · BlackRock, Inc. · Apr 27, 2026